Hervé Chambost

Professor and Head of the Comprehensive Care Centre for Congenital Bleeding Disorders
AP-HM, Department of Pediatric Hematology Oncology, Children Hospital La Timone & Aix Marseille University, INSERM, INRA, C2VN, Marseille, France
Marseille, Provence-Alpes-Cote d'Azur, France

Presentation(s):

• OC 20.1 - Bleeding, FVIII activity, and safety 3 years after gene transfer with valoctocogene roxaparvovec: Results from GENEr8-1

  Sunday, June 25, 2023
  14:45 – 15:00 ET

• OC 43.1 - A survey on clinical praxis in initiating emicizumab prophylaxis in previously untreated patients in the PedNet centers

  Monday, June 26, 2023
  14:45 – 15:00 ET

• PB0638 - Final data from A-MOVE: 12-Month Prospective Multicentre Study to Investigate the Impact of Systematic Joint Examination on Treatment Management Decisions in Patients with Hemophilia A in France

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0650 - Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Pediatric Patients with Hemophilia B: A review of results from Phase 3 trial studies

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB1249 - Prospective, Observational Study of the Clinical Characteristics of Adults and Adolescents With Severe Hemophilia A

  Tuesday, June 27, 2023
  18:30 – 19:30 ET